Hot off the press! Our very own Chief Scientific Officer Dr. Laurence Hurley honored in a special issue.

Congratulations to Reglagene's Chief Scientific Officer Dr. Laurence Hurley for the granting of FDA Fast Track status for Pidnarulex, the only DNA quadruplex-targeting therapy that is active in human clinical trials.

Congratulations to our Scientific Advisor Dr. Matthew Marx, co-inventor of the clinical KRAS G12C inhibitor adagrasib, which was recently voted #2 drug of the year.

It was a great way to celebrate International Women's Day as Dr. Teri Suzuki presented at the Eureka Institute Conference.

We’re honored to be recognized as an up-and-comer in the life science arena.

Our team had a great time at the Copper Cactus Awards at Casino Del Sol sporting our “Zoom attire.”

Receiving funding from the Desert Angels helped kickstart Reglagene’s drug discovery and development engine.

Reglagene was featured in the Arizona Daily Star!

Thank you Cancer Fund for featuring us in your recent webinar.